Cite
APA Citation
Ogawa, H., Sakai, Y., Nishio, W., Fujibayashi, Y., Nishikubo, M., Nishioka, Y., Tane, S., Kitamura, Y., Sudo, T., Sakuma, T., & Yoshimura, M. (2020). dLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC. Thoracic cancer, 11(9), 2561–2569. http://access.bl.uk/ark:/81055/vdc_100107619096.0x00001d